MOVES: New CEO for Swiss drug company Roche
19 July 2007 13:52 [Source: ICIS news]
LONDON (ICIS news)--Swiss pharmaceuticals firm the Roche Group announced today that Severin Schwan will succeed Franz Humer as CEO.
Schwan is currently CEO of Roche Diagnostics.
Humer, who is presently CEO and chairman, will remain as Roche Group chairman and also become chairman of Diageo, the
Humer said in a statement that the board had decided to separate the chairman and CEO roles because of the increasing complexity of the tasks involved.
By: Lucy Craymer
+44 20 8652 3214
< previous article(ICIS Chemical Business podcast November 2, 2009)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Links posted in this story:
|
|
Related Articles
- 30 Jan 08 13:36 Roche posts 22.3% rise in 2007 operating profit
- 02 Oct 07 17:36 US Codexis releases biocatalyst panels at CPhI
- 19 Jul 07 08:29 Roche operating profits rise 29% in first half
- 28 Jun 07 15:13 DSM expects lay-offs in nutrition profits plan
- 18 Apr 07 08:40 Roche Q1 sales up 16% on pharmaceuticals
- 07 Feb 07 07:08 Roche 2006 op profit rises 28% on strong sales
Latest News
- 27 Nov 09 13:58 Further Europe December C2 and C3 settlements reported
- 27 Nov 09 13:31 VIDEO - ICIS news Europe Lunchtime Bulletin 27 November 2009
- 27 Nov 09 13:21 Poland's ZChP will be sold to strategic investor
- 27 Nov 09 13:07 Borealis reviews future of rotational moulding resins business
- 27 Nov 09 12:49 Europe December benzene contract expected to settle up $31-36/t
Barbara Ortner looks at the off-beat and unusual side of chemical industry life.
ICIS Chemicals Confidential